308 related articles for article (PubMed ID: 23696960)
1. Molecularly targeted therapies for advanced or metastatic non-small-cell lung carcinoma.
Bayraktar S; Rocha-Lima CM
World J Clin Oncol; 2013 May; 4(2):29-42. PubMed ID: 23696960
[TBL] [Abstract][Full Text] [Related]
2. Personalized medicine in metastatic non-small-cell lung cancer: promising targets and current clinical trials.
Black A; Morris D
Curr Oncol; 2012 Jun; 19(Suppl 1):S73-85. PubMed ID: 22787415
[TBL] [Abstract][Full Text] [Related]
3. Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(24):1-48. PubMed ID: 23074402
[TBL] [Abstract][Full Text] [Related]
4. Update of epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer.
Chen YM
J Chin Med Assoc; 2013 May; 76(5):249-57. PubMed ID: 23683257
[TBL] [Abstract][Full Text] [Related]
5. Molecular Targets in Non-Small Cell Lung Cancer.
Griffin R; Ramirez RA
Ochsner J; 2017; 17(4):388-392. PubMed ID: 29230123
[TBL] [Abstract][Full Text] [Related]
6. Targeting
Baik CS; Myall NJ; Wakelee HA
Oncologist; 2017 Jul; 22(7):786-796. PubMed ID: 28487464
[TBL] [Abstract][Full Text] [Related]
7. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
Greenhalgh J; Boland A; Bates V; Vecchio F; Dundar Y; Chaplin M; Green JA
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD010383. PubMed ID: 33734432
[TBL] [Abstract][Full Text] [Related]
8. Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review.
Arbour KC; Riely GJ
JAMA; 2019 Aug; 322(8):764-774. PubMed ID: 31454018
[TBL] [Abstract][Full Text] [Related]
9. An update on biomarkers for kinase inhibitor response in non-small-cell lung cancer.
Ku BM; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ
Expert Rev Mol Diagn; 2017 Oct; 17(10):933-942. PubMed ID: 28838271
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapies for non-small cell lung cancer.
Dempke WC; Suto T; Reck M
Lung Cancer; 2010 Mar; 67(3):257-74. PubMed ID: 19914732
[TBL] [Abstract][Full Text] [Related]
11. A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506).
Zhou Q; Song Y; Zhang X; Chen GY; Zhong DS; Yu Z; Yu P; Zhang YP; Chen JH; Hu Y; Feng GS; Song X; Shi Q; Yang LL; Zhang PH; Wu YL
BMC Cancer; 2017 Jul; 17(1):462. PubMed ID: 28673332
[TBL] [Abstract][Full Text] [Related]
12. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
Greenhalgh J; Dwan K; Boland A; Bates V; Vecchio F; Dundar Y; Jain P; Green JA
Cochrane Database Syst Rev; 2016 May; (5):CD010383. PubMed ID: 27223332
[TBL] [Abstract][Full Text] [Related]
13. Targeted therapy for non-small cell lung cancer: current standards and the promise of the future.
Chan BA; Hughes BG
Transl Lung Cancer Res; 2015 Feb; 4(1):36-54. PubMed ID: 25806345
[TBL] [Abstract][Full Text] [Related]
14. Targeted therapies in development for non-small cell lung cancer.
Reungwetwattana T; Dy GK
J Carcinog; 2013; 12():22. PubMed ID: 24574860
[TBL] [Abstract][Full Text] [Related]
15. Epidermal Growth Factor Receptor Inhibition in the Management of Squamous Cell Carcinoma of the Lung.
Goss GD; Spaans JN
Oncologist; 2016 Feb; 21(2):205-13. PubMed ID: 26768483
[TBL] [Abstract][Full Text] [Related]
16. Pemetrexed With Platinum Combination as a Backbone for Targeted Therapy in Non-Small-Cell Lung Cancer.
Stinchcombe TE; Borghaei H; Barker SS; Treat JA; Obasaju C
Clin Lung Cancer; 2016 Jan; 17(1):1-9. PubMed ID: 26340853
[TBL] [Abstract][Full Text] [Related]
17. Current treatments for advanced stage non-small cell lung cancer.
Stinchcombe TE; Socinski MA
Proc Am Thorac Soc; 2009 Apr; 6(2):233-41. PubMed ID: 19349493
[TBL] [Abstract][Full Text] [Related]
18. Targeted therapies for treatment of non-small cell lung cancer--Recent advances and future perspectives.
Minguet J; Smith KH; Bramlage P
Int J Cancer; 2016 Jun; 138(11):2549-61. PubMed ID: 26537995
[TBL] [Abstract][Full Text] [Related]
19. Advances in the Development of Molecularly Targeted Agents in Non-Small-Cell Lung Cancer.
Dolly SO; Collins DC; Sundar R; Popat S; Yap TA
Drugs; 2017 May; 77(8):813-827. PubMed ID: 28378229
[TBL] [Abstract][Full Text] [Related]
20. The PI3k inhibitors: new hopes in the battle against advanced NSCLC.
Sacco PC; Maione P; Rossi A; Barecshino MA; Sgambato A; Casaluce F; Napolitano A; Palazzolo G; Rossi E; Ferrara C; Gridelli C
Front Biosci (Landmark Ed); 2014 Jan; 19(2):259-71. PubMed ID: 24389182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
